ImpediMed Limited (IPD.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 10.31 Million | 11.34 Million | 10.56 Million | 8.4 Million | 5.74 Million | 4.15 Million |
| Cost of Revenue | 1.31 Million | 24.99 Million | 23.91 Million | 20.61 Million | 18.62 Million | 1.25 Million |
| Gross Profit | 9 Million | -13.65 Million | -13.35 Million | -12.2 Million | -12.88 Million | 2.9 Million |
| Operating Expenses | 28.04 Million | 9.19 Million | 7.87 Million | 10.81 Million | 12.62 Million | 27.22 Million |
| Selling, General and Administrative Expenses | 22.61 Million | 8.59 Million | 7.19 Million | 9.35 Million | 9.31 Million | 22.83 Million |
| Research and Development Expenses | 221 Thousand | 598 Thousand | 683 Thousand | 1.45 Million | 3.3 Million | 3.36 Million |
| Other Expenses | - | 1.7 Million | 1.69 Million | 2.43 Million | 4.18 Million | 2.69 Million |
| Cost and Expenses | 29.35 Million | 34.19 Million | 31.79 Million | 31.42 Million | 31.25 Million | 28.47 Million |
| Operating Income | -19.03 Million | -22.84 Million | -21.22 Million | -23.01 Million | -25.51 Million | -26.96 Million |
| Interest Expense | 93 Thousand | 34 Thousand | 28 Thousand | 52 Thousand | 73 Thousand | - |
| Income Tax Expense | -935 Thousand | -1.55 Million | -1.57 Million | -1.74 Million | -2.55 Million | 51 Thousand |
| Earnings before Tax | -20.72 Million | -22.07 Million | -21.44 Million | -22.45 Million | -23.93 Million | -23.94 Million |
| Net Income | -19.79 Million | -20.52 Million | -19.87 Million | -20.7 Million | -21.37 Million | -23.99 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.06 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.06 |
| Weighted Average Shares Outstanding | 2.02 Billion | 1.8 Billion | 1.67 Billion | 1.2 Billion | 595.16 Million | 397.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.02 Billion | 1.8 Billion | 1.67 Billion | 1.2 Billion | 595.16 Million | 397.43 Million |
| Gross Margin | 0.87 | -1.20 | -1.26 | -1.45 | -2.24 | 0.70 |
| EBIT Margin | -2.14 | -1.80 | -1.75 | -2.54 | -4.19 | -6.43 |
| Profit Margin | -1.92 | -1.81 | -1.88 | -2.46 | -3.72 | -5.77 |
| EBITDA | -22.05 Million | -20.49 Million | -18.65 Million | -20.7 Million | -24.07 Million | -26.33 Million |
| Earnings Before Tax Margin | -1.84 | -2.01 | -2.01 | -2.74 | -4.44 | -6.49 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 10.31 Million | 5.53 Million | 4.78 Million | 5.68 Million | 11.34 Million | 5.65 Million |
| Cost of Revenue | 24.29 Million | 682 Thousand | 12.61 Million | 12.1 Million | 24.99 Million | 12.72 Million |
| Gross Profit | -13.97 Million | 4.85 Million | -7.82 Million | -6.41 Million | -13.65 Million | -7.06 Million |
| Operating Expenses | 9.99 Million | -5.67 Million | 4.25 Million | 4.05 Million | 9.19 Million | 4.76 Million |
| Selling, General and Administrative Expenses | - | 11.73 Million | 4.13 Million | 3.94 Million | - | 4.28 Million |
| Research and Development Expenses | - | 1.76 Million | 125 Thousand | 111 Thousand | - | 487 Thousand |
| Other Expenses | 3.08 Million | -19.18 Million | - | - | 1.7 Million | - |
| Cost and Expenses | 34.29 Million | -4.99 Million | 16.86 Million | 16.16 Million | 34.19 Million | 17.49 Million |
| Operating Income | -23.97 Million | 10.53 Million | -12.08 Million | -10.47 Million | -22.84 Million | -11.83 Million |
| Interest Expense | 93 Thousand | 44 Thousand | 49 Thousand | 29 Thousand | 34 Thousand | 5000.00 |
| Income Tax Expense | -935 Thousand | 13 Thousand | -518 Thousand | -496 Thousand | -1.55 Million | -1.05 Million |
| Earnings before Tax | -20.72 Million | -10.05 Million | -10.23 Million | -10.2 Million | -22.07 Million | -11.87 Million |
| Net Income | -19.79 Million | -10.07 Million | -9.71 Million | -9.7 Million | -20.52 Million | -10.81 Million |
| Earnings Per Share Basic | - | -0.00 | -0.00 | -0.01 | - | -0.01 |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.01 | - | -0.01 |
| Weighted Average Shares Outstanding | 2.02 Billion | 2.04 Billion | 1.99 Billion | 1.82 Billion | 1.8 Billion | 1.78 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.02 Billion | 2.04 Billion | 1.99 Billion | 1.82 Billion | 1.8 Billion | 1.78 Billion |
| Gross Margin | -1.35 | 0.88 | -1.64 | -1.13 | -1.20 | -1.25 |
| EBIT Margin | - | -2.11 | -2.28 | -1.61 | - | -1.89 |
| Profit Margin | -1.92 | -1.82 | -2.03 | -1.71 | -1.81 | -1.91 |
| EBITDA | - | -11.7 Million | -10.92 Million | -9.16 Million | - | -10.67 Million |
| Earnings Before Tax Margin | -2.32 | 1.90 | -2.53 | -1.84 | -2.01 | -2.09 |
AMEZ
8310
DTCK
CVRX
SUPER
ZBRA